2DQ5
| solution structure of the Mid1 B Box2 Chc(D/C)C2H2 Zinc-Binding Domain: insights into an evolutionary conserved ring fold | Descriptor: | Midline-1, ZINC ION | Authors: | Massiah, M.A, Matts, J.A.B, Short, K.M, Simmons, B.N, Singireddy, S, Zou, J, Cox, T.C. | Deposit date: | 2006-05-20 | Release date: | 2007-04-03 | Last modified: | 2024-05-29 | Method: | SOLUTION NMR | Cite: | Solution Structure of the MID1 B-box2 CHC(D/C)C(2)H(2) Zinc-binding Domain: Insights into an Evolutionarily Conserved RING Fold J.Mol.Biol., 369, 2007
|
|
1CKX
| Cystic fibrosis transmembrane conductance regulator: Solution structures of peptides based on the Phe508 region, the most common site of disease-causing Delta-F508 mutation | Descriptor: | Cystic fibrosis transmembrane conductance regulator (CFTR) | Authors: | Massiah, M.A, Ko, Y.H, Pedersen, P.L, Mildvan, A.S. | Deposit date: | 1999-04-26 | Release date: | 1999-05-04 | Last modified: | 2023-12-27 | Method: | SOLUTION NMR | Cite: | Cystic fibrosis transmembrane conductance regulator: solution structures of peptides based on the Phe508 region, the most common site of disease-causing DeltaF508 mutation. Biochemistry, 38, 1999
|
|
1CKY
| CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR: SOLUTION STRUCTURES OF PEPTIDES BASED ON THE PHE508 REGION, THE MOST COMMON SITE OF DISEASE-CAUSING DELTA-F508 MUTATION | Descriptor: | PROTEIN (CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR)) | Authors: | Massiah, M.A, Ko, Y.H, Pedersen, P.L, Mildvan, A.S. | Deposit date: | 1999-04-26 | Release date: | 1999-05-04 | Last modified: | 2023-12-27 | Method: | SOLUTION NMR | Cite: | Cystic fibrosis transmembrane conductance regulator: solution structures of peptides based on the Phe508 region, the most common site of disease-causing DeltaF508 mutation. Biochemistry, 38, 1999
|
|
2FFW
| Solution structure of the RBCC/TRIM B-box1 domain of human MID1: B-box with a RING | Descriptor: | Midline-1, ZINC ION | Authors: | Massiah, M.A, Simmons, B.N, Short, K.M, Cox, T.C. | Deposit date: | 2005-12-20 | Release date: | 2006-05-09 | Last modified: | 2024-05-29 | Method: | SOLUTION NMR | Cite: | Solution Structure of the RBCC/TRIM B-box1 Domain of Human MID1: B-box with a RING. J.Mol.Biol., 358, 2006
|
|
2HMX
| HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 MATRIX PROTEIN | Descriptor: | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 MATRIX PROTEIN | Authors: | Massiah, M.A, Starich, M.R, Paschall, C, Christensen, A.M, Sundquist, W.I, Summers, M.F. | Deposit date: | 1995-09-22 | Release date: | 1996-01-29 | Last modified: | 2024-05-29 | Method: | SOLUTION NMR | Cite: | Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J.Mol.Biol., 244, 1994
|
|
1BUQ
| SOLUTION STRUCTURE OF DELTA-5-3-KETOSTEROID ISOMERASE COMPLEXED WITH THE STEROID 19-NORTESTOSTERONE-HEMISUCCINATE | Descriptor: | PROTEIN (3-KETOSTEROID ISOMERASE-19-NORTESTOSTERONE-HEMISUCCINATE), SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER | Authors: | Massiah, M.A, Abeygunawardana, C, Gittis, A.G, Mildvan, A.S. | Deposit date: | 1998-09-04 | Release date: | 1999-01-20 | Last modified: | 2024-05-22 | Method: | SOLUTION NMR | Cite: | Solution structure of Delta 5-3-ketosteroid isomerase complexed with the steroid 19-nortestosterone hemisuccinate. Biochemistry, 37, 1998
|
|
1CKW
| CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR: SOLUTION STRUCTURES OF PEPTIDES BASED ON THE PHE508 REGION, THE MOST COMMON SITE OF DISEASE-CAUSING DELTA-F508 MUTATION | Descriptor: | PROTEIN (CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR)) | Authors: | Massiah, M.A, Ko, Y.H, Pedersen, P.L, Mildvan, A.S. | Deposit date: | 1999-04-26 | Release date: | 1999-05-04 | Last modified: | 2023-12-27 | Method: | SOLUTION NMR | Cite: | Cystic fibrosis transmembrane conductance regulator: solution structures of peptides based on the Phe508 region, the most common site of disease-causing DeltaF508 mutation. Biochemistry, 38, 1999
|
|
1CKZ
| CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR: SOLUTION STRUCTURES OF PEPTIDES BASED ON THE PHE508 REGION, THE MOST COMMON SITE OF DISEASE-CAUSING DELTA-F508 MUTATION | Descriptor: | PROTEIN (CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR)) | Authors: | Massiah, M.A, Ko, Y.H, Pedersen, P.L, Mildvan, A.S. | Deposit date: | 1999-04-26 | Release date: | 1999-05-04 | Last modified: | 2023-12-27 | Method: | SOLUTION NMR | Cite: | Cystic fibrosis transmembrane conductance regulator: solution structures of peptides based on the Phe508 region, the most common site of disease-causing DeltaF508 mutation. Biochemistry, 38, 1999
|
|
1PUS
| Solution Structure of the MutT Pyrophosphohydrolase Complexed with Mg(2+) and 8-oxo-dGMP, a Tightly-bound Product | Descriptor: | 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE, MAGNESIUM ION, Mutator mutT protein | Authors: | Massiah, M.A, Saraswat, V, Azurmendi, H.F, Mildvan, A.S. | Deposit date: | 2003-06-25 | Release date: | 2003-08-26 | Last modified: | 2024-05-01 | Method: | SOLUTION NMR | Cite: | Solution structure and NH exchange studies of the MutT pyrophosphohydrolase complexed with Mg(2+) and 8-oxo-dGMP, a tightly bound product. Biochemistry, 42, 2003
|
|
1PUN
| Solution Structure of the MutT Pyrophosphohydrolase Complexed with Mg(2+) and 8-oxo-dGMP, a Tightly-bound Product | Descriptor: | 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE, MAGNESIUM ION, Mutator mutT protein | Authors: | Massiah, M.A, Saraswat, V, Azurmendi, H.F, Mildvan, A.S. | Deposit date: | 2003-06-25 | Release date: | 2003-08-26 | Last modified: | 2024-05-22 | Method: | SOLUTION NMR | Cite: | Solution structure and NH exchange studies of the MutT pyrophosphohydrolase complexed with Mg(2+) and 8-oxo-dGMP, a tightly bound product. Biochemistry, 42, 2003
|
|
1PUQ
| Solution Structure of the MutT Pyrophosphohydrolase Complexed with Mg(2+) and 8-oxo-dGMP, a Tightly-bound Product | Descriptor: | 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE, MAGNESIUM ION, Mutator mutT protein | Authors: | Massiah, M.A, Saraswat, V, Azurmendi, H.F, Mildvan, A.S. | Deposit date: | 2003-06-25 | Release date: | 2003-08-26 | Last modified: | 2024-05-01 | Method: | SOLUTION NMR | Cite: | Solution structure and NH exchange studies of the MutT pyrophosphohydrolase complexed with Mg(2+) and 8-oxo-dGMP, a tightly bound product. Biochemistry, 42, 2003
|
|
1PPX
| Solution Structure of the MutT Pyrophosphohydrolase Complexed with Mg(2+) and 8-oxo-dGMP, a Tightly-bound Product | Descriptor: | 8-OXO-2'-DEOXY-GUANOSINE-5'-MONOPHOSPHATE, MAGNESIUM ION, Mutator mutT protein | Authors: | Massiah, M.A, Saraswat, V, Azurmendi, H.F, Mildvan, A.S. | Deposit date: | 2003-06-17 | Release date: | 2003-08-26 | Last modified: | 2024-05-22 | Method: | SOLUTION NMR | Cite: | Solution structure and NH exchange studies of the MutT pyrophosphohydrolase complexed with Mg(2+) and 8-oxo-dGMP, a tightly bound product. Biochemistry, 42, 2003
|
|
5IM8
| |
2JUN
| Structure of the MID1 tandem B-boxes reveals an interaction reminiscent of intermolecular RING heterodimers | Descriptor: | Midline-1, ZINC ION | Authors: | Tao, H, Singireddy, S, Jakkidi, M, Simmons, B.N, Short, K.M, Cox, T.C, Massiah, M.A. | Deposit date: | 2007-08-31 | Release date: | 2008-03-04 | Last modified: | 2024-05-29 | Method: | SOLUTION NMR | Cite: | Structure of the MID1 Tandem B-Boxes Reveals an Interaction Reminiscent of Intermolecular Ring Heterodimers Biochemistry, 47, 2008
|
|
1IK4
| X-ray Structure of Methylglyoxal Synthase from E. coli Complexed with Phosphoglycolohydroxamic Acid | Descriptor: | METHYLGLYOXAL SYNTHASE, PHOSPHOGLYCOLOHYDROXAMIC ACID | Authors: | Marks, G.T, Harris, T.K, Massiah, M.A, Mildvan, A.S, Harrison, D.H.T. | Deposit date: | 2001-05-02 | Release date: | 2001-09-26 | Last modified: | 2024-02-07 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | Mechanistic implications of methylglyoxal synthase complexed with phosphoglycolohydroxamic acid as observed by X-ray crystallography and NMR spectroscopy. Biochemistry, 40, 2001
|
|
1JVR
| STRUCTURE OF THE HTLV-II MATRIX PROTEIN, NMR, 20 STRUCTURES | Descriptor: | HUMAN T-CELL LEUKEMIA VIRUS TYPE II MATRIX PROTEIN | Authors: | Christensen, A.M, Massiah, M.A, Turner, B.G, Sundquist, W.I, Summers, M.F. | Deposit date: | 1996-10-03 | Release date: | 1997-03-12 | Last modified: | 2024-05-22 | Method: | SOLUTION NMR | Cite: | Three-dimensional structure of the HTLV-II matrix protein and comparative analysis of matrix proteins from the different classes of pathogenic human retroviruses. J.Mol.Biol., 264, 1996
|
|